![Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan - Value in Health Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan - Value in Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/78d84709-d7d7-4750-93d5-c7ceee0c951b/gr1.jpg)
Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan - Value in Health
![Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness - Harvard Business School Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness - Harvard Business School](https://www.isc.hbs.edu/PublishingImages/value-based-health-care/measuring-costs.png)
Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness - Harvard Business School
![Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris - American Journal of Cardiology Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2c29886a-2b22-4794-ab4f-fea6f43847a3/gr1.jpg)
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris - American Journal of Cardiology
![Medical Costs and Readmissions After Intensive Poststroke Rehabilitation: Japanese Claims Data - Journal of the American Medical Directors Association Medical Costs and Readmissions After Intensive Poststroke Rehabilitation: Japanese Claims Data - Journal of the American Medical Directors Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d698a5c8-8e4e-466f-bb0f-411d67bba0bb/gr1.jpg)
Medical Costs and Readmissions After Intensive Poststroke Rehabilitation: Japanese Claims Data - Journal of the American Medical Directors Association
![Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness - Harvard Business School Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness - Harvard Business School](https://www.isc.hbs.edu/PublishingImages/value-based-health-care/outcome-measures-hierarchy.png)
Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness - Harvard Business School
![Comparison of the medical costs, (a) per patient per month (PPPM) and... | Download Scientific Diagram Comparison of the medical costs, (a) per patient per month (PPPM) and... | Download Scientific Diagram](https://www.researchgate.net/publication/319483579/figure/fig3/AS:535204911878144@1504614202033/Comparison-of-the-medical-costs-a-per-patient-per-month-PPPM-and-b-per-member-per.png)
Comparison of the medical costs, (a) per patient per month (PPPM) and... | Download Scientific Diagram
![Renee Unveils Aggressively Low-Cost Prescription Drug Plan: $25 Per Month for Most Popular Medications Needed by Subscribers | Business Wire Renee Unveils Aggressively Low-Cost Prescription Drug Plan: $25 Per Month for Most Popular Medications Needed by Subscribers | Business Wire](https://mms.businesswire.com/media/20221025005081/en/1606211/5/IMAGE_Renee_Prescription_Plan_Service_As_of_October_18_2022.jpg)
Renee Unveils Aggressively Low-Cost Prescription Drug Plan: $25 Per Month for Most Popular Medications Needed by Subscribers | Business Wire
![Predicting outcome of patients with prolonged disorders of consciousness using machine learning models based on medical complexity | Scientific Reports Predicting outcome of patients with prolonged disorders of consciousness using machine learning models based on medical complexity | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-17561-w/MediaObjects/41598_2022_17561_Fig1_HTML.png)